Ebewe, Sanofi Come To Terms Over Eloxatin Patent
As part of a settlement agreement, Austrian pharmaceutical company Ebewe Pharma Ges.m.b.H. Nfg.KG has agreed to stipulate that it infringed the patents covering Sanofi-Aventis' colon cancer drug Eloxatin....To view the full article, register now.
Already a subscriber? Click here to view full article